• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术(TIPS)后再入院率、再入院原因、预测因素和负担。

Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement.

机构信息

Department of Medicine, West Virginia University Health Sciences Center Charleston Division, Charleston, West Virginia, USA.

Department of Medicine, Maimonides Medical Center, New York, New York, USA.

出版信息

J Gastroenterol Hepatol. 2021 Mar;36(3):775-781. doi: 10.1111/jgh.15194. Epub 2020 Sep 8.

DOI:10.1111/jgh.15194
PMID:32710679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8385676/
Abstract

BACKGROUND AND AIM

Nationwide data on readmissions after the transjugular intrahepatic portosystemic shunt (TIPS) procedure are lacking. We aimed to investigate the 30-day readmission rate after TIPS procedure, reasons, and predictors for readmissions and its impact on resource utilization and mortality in the USA.

METHODS

We identified all adults who underwent an inpatient TIPS procedure between 2010 and 2014 using the National Readmission Database. Outcomes included all-cause 30-day readmission rate, reasons and predictors of readmissions, mortality rate, and mean hospitalization charges.

RESULTS

Out of a total of 31 230 hospitalizations with TIPS procedure, 28 021 patients met the study criteria and were finally included. The mean age of patients was 56.90 years, and 63.84% were men. All-cause 30-day readmission rate was 27.81%. Hepatic encephalopathy with or without coma was the most common reason for readmissions in at least 36.43% patients. The in-hospital mortality for index hospitalization and 30-day readmission was 10.69% and 5.85%, respectively. The mean hospitalization charges for index hospitalization and readmissions were $153 357 and $45 751, respectively. Advanced age, Medicaid insurance, higher Charlson comorbidy index, ascites as indication of TIPS, and nonspecific or hepatitis C cirrhosis etiologies for cirrhosis were found to be independent predictors of 30-day readmissions after a TIPS procedure.

CONCLUSIONS

Our study found a high rate of readmission for patients undergoing TIPS procedure, and the majority of these readmissions were related to hepatic encephalopathy. Further studies highlighting areas for improvement, particularly for patient selection and post-discharge care, are needed to reduce readmissions.

摘要

背景与目的

目前缺乏关于经颈静脉肝内门体分流术(TIPS)后再入院的全国性数据。本研究旨在调查美国 TIPS 术后 30 天再入院率、再入院的原因和预测因素,及其对资源利用和死亡率的影响。

方法

我们使用国家再入院数据库,确定了 2010 年至 2014 年间所有接受住院 TIPS 治疗的成年人。主要结局为全因 30 天再入院率、再入院的原因和预测因素、死亡率以及平均住院费用。

结果

在总共 31230 例 TIPS 治疗的住院患者中,有 28021 例符合研究标准,最终被纳入研究。患者的平均年龄为 56.90 岁,63.84%为男性。全因 30 天再入院率为 27.81%。肝性脑病伴或不伴昏迷是至少 36.43%患者再入院的最常见原因。指数住院期间和 30 天再入院的院内死亡率分别为 10.69%和 5.85%。指数住院和再入院的平均住院费用分别为 153357 美元和 45751 美元。高龄、医疗补助保险、较高的 Charlson 合并症指数、腹水作为 TIPS 适应证以及非特异性或丙型肝炎肝硬化病因被发现是 TIPS 术后 30 天再入院的独立预测因素。

结论

我们的研究发现,接受 TIPS 治疗的患者再入院率较高,其中大多数再入院与肝性脑病有关。需要进一步研究以确定需要改进的领域,特别是在患者选择和出院后护理方面,以降低再入院率。

相似文献

1
Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement.经颈静脉肝内门体分流术(TIPS)后再入院率、再入院原因、预测因素和负担。
J Gastroenterol Hepatol. 2021 Mar;36(3):775-781. doi: 10.1111/jgh.15194. Epub 2020 Sep 8.
2
Lower 90-day Hospital Readmission Rates for Esophageal Variceal Bleeding After TIPS: A Nationwide Linked Analysis.经 TIPS 治疗后的食管静脉曲张出血患者 90 天内的再入院率较低:一项全国性关联分析。
J Clin Gastroenterol. 2020 Jan;54(1):90-95. doi: 10.1097/MCG.0000000000001199.
3
Causes and Rates of 30-Day Readmissions After Transjugular Intrahepatic Portosystemic Shunts.经颈静脉肝内门体分流术后 30 天再入院的原因和比率。
AJR Am J Roentgenol. 2020 Jul;215(1):235-241. doi: 10.2214/AJR.19.21732. Epub 2020 May 6.
4
Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial.晚期肝硬化患者经颈静脉肝内门体分流术通过门静脉左支与右支的疗效比较:一项随机试验
Liver Int. 2009 Aug;29(7):1101-9. doi: 10.1111/j.1478-3231.2009.02016.x. Epub 2009 Apr 6.
5
Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.83884例经颈静脉肝内门体分流术患者住院死亡率的全国趋势及预测因素
World J Gastroenterol. 2016 Jul 7;22(25):5780-9. doi: 10.3748/wjg.v22.i25.5780.
6
Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.10mm 覆盖型经颈静脉肝内门体分流术后肝硬化患者的长期临床转归和生存预测因素。
Gastroenterol Hepatol. 2021 Nov;44(9):620-627. doi: 10.1016/j.gastrohep.2020.10.018. Epub 2020 Nov 26.
7
Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.美国急性食管静脉曲张出血住院患者的早期经颈静脉肝内门体分流术
J Gastroenterol Hepatol. 2017 Apr;32(4):852-858. doi: 10.1111/jgh.13593.
8
Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.经颈静脉肝内门体分流术时经皮穿刺左支门静脉以减少肝性脑病。
World J Gastroenterol. 2019 Mar 7;25(9):1088-1099. doi: 10.3748/wjg.v25.i9.1088.
9
Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience.经颈静脉肝内门体分流术后的医院再入院:一项为期14年的单中心经验。
Gastroenterol Rep (Oxf). 2019 Nov 28;8(2):98-103. doi: 10.1093/gastro/goz062. eCollection 2020 Apr.
10
MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.MELD 或 Sodium MELD:两种评分系统预测经颈静脉肝内门体分流术放置后结局的能力比较。
AJR Am J Roentgenol. 2020 Jul;215(1):215-222. doi: 10.2214/AJR.19.21726. Epub 2020 May 20.

引用本文的文献

1
Controlled expansion stent grafts versus legacy stent grafts for transjugular intrahepatic portosystemic shunt: a single-centre retrospective study on the incidence of hepatic encephalopathy.经颈静脉肝内门体分流术使用可控扩张式支架移植物与传统支架移植物的比较:关于肝性脑病发生率的单中心回顾性研究
CVIR Endovasc. 2025 May 24;8(1):48. doi: 10.1186/s42155-025-00557-8.
2
Carvedilol and traditional nonselective beta blockers for the secondary prophylaxis of variceal hemorrhage and portal hypertension related complications among patients with decompensated cirrhosis: a systematic review and network meta-analysis.卡维地洛与传统非选择性β受体阻滞剂用于失代偿期肝硬化患者静脉曲张出血及门静脉高压相关并发症的二级预防:一项系统评价与网状Meta分析
Hepatol Int. 2025 Apr 3. doi: 10.1007/s12072-025-10812-8.
3
Numerous liver abscesses after transjugular intrahepatic portosystemic shunt for decompensated liver cirrhosis: A case report.经颈静脉肝内门体分流术治疗失代偿期肝硬化后出现大量肝脓肿:一例报告
World J Radiol. 2025 Feb 28;17(2):101932. doi: 10.4329/wjr.v17.i2.101932.
4
Comparison of clinical outcomes of transjugular intrahepatic portosystemic shunt for refractory ascites and recurrent nonrefractory ascites.经颈静脉肝内门体分流术治疗顽固性腹水和复发性非顽固性腹水的临床结局比较。
World J Hepatol. 2025 Feb 27;17(2):100451. doi: 10.4254/wjh.v17.i2.100451.
5
Clinical Outcomes of Transjugular Intrahepatic Portosystemic Shunt Among Cirrhosis Patients With Recurrent Esophageal Variceal Bleeding.经颈静脉肝内门体分流术治疗肝硬化合并复发性食管静脉曲张出血患者的临床结局
Cureus. 2024 Nov 5;16(11):e73101. doi: 10.7759/cureus.73101. eCollection 2024 Nov.
6
Correlation between serum markers and transjugular intrahepatic portosystemic shunt prognosis in patients with cirrhotic ascites.肝硬化腹水患者血清标志物与经颈静脉肝内门体分流术预后的相关性
World J Gastrointest Surg. 2024 Feb 27;16(2):481-490. doi: 10.4240/wjgs.v16.i2.481.
7
Hospital Utilization for Patients With Cirrhosis and Severe Ascites in a Model of Outpatient Paracentesis by Interventional Radiology.介入放射学门诊腹腔穿刺术模式下肝硬化合并严重腹水患者的医院利用情况。
Cureus. 2023 Dec 31;15(12):e51397. doi: 10.7759/cureus.51397. eCollection 2023 Dec.
8
Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) Hepatic Encephalopathy-A Review of the Past Decade's Literature Focusing on Incidence, Risk Factors, and Prophylaxis.经颈静脉肝内门体分流术(TIPS)相关性肝性脑病——基于发病率、危险因素及预防的过去十年文献综述
J Clin Med. 2023 Dec 19;13(1):14. doi: 10.3390/jcm13010014.
9
Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.经颈静脉肝内门体分流术时降低门体系统梯度可获得良好的效果,并减少并发症。
World J Gastroenterol. 2023 Apr 21;29(15):2336-2348. doi: 10.3748/wjg.v29.i15.2336.
10
Right vs left portal branch puncture in TIPS creation with controlled expansion covered stent: comparison of hemodynamic and clinical outcomes.经覆膜支架控制扩张下 TIPS 中右/左门静脉分支穿刺:血流动力学和临床结局比较。
Eur Radiol. 2023 Apr;33(4):2647-2654. doi: 10.1007/s00330-022-09280-7. Epub 2022 Dec 1.

本文引用的文献

1
Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience.经颈静脉肝内门体分流术后的医院再入院:一项为期14年的单中心经验。
Gastroenterol Rep (Oxf). 2019 Nov 28;8(2):98-103. doi: 10.1093/gastro/goz062. eCollection 2020 Apr.
2
Emergency Transjugular Intrahepatic Portosystemic Shunt: an Effective and Safe Treatment for Uncontrolled Variceal Bleeding.急诊经颈静脉肝内门体分流术:治疗未控制的静脉曲张出血的有效且安全的方法。
J Gastrointest Surg. 2019 Nov;23(11):2193-2200. doi: 10.1007/s11605-019-04146-8. Epub 2019 Feb 21.
3
Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States.美国肝硬化患者再住院的全国估计数和危险因素。
Liver Int. 2019 May;39(5):878-884. doi: 10.1111/liv.14054. Epub 2019 Feb 25.
4
Validation of Risk Score in Predicting Early Readmissions in Decompensated Cirrhotic Patients: A Model Based on the Administrative Database.基于行政数据库的失代偿期肝硬化患者早期再入院风险评分模型的验证。
Hepatology. 2019 Aug;70(2):630-639. doi: 10.1002/hep.30274. Epub 2019 Feb 19.
5
Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.经颈静脉肝内门体分流术(TIPS)后肝性脑病的发生率,根据其严重程度和时间分级分类。
Radiol Med. 2017 Sep;122(9):713-721. doi: 10.1007/s11547-017-0770-6. Epub 2017 May 16.
6
Further Evidence on the System-Wide Effects of the Hospital Readmissions Reduction Program.进一步的证据表明医院再入院率降低计划对整个系统的影响。
Health Serv Res. 2018 Jun;53(3):1478-1497. doi: 10.1111/1475-6773.12701. Epub 2017 May 8.
7
The Relevance of Readmissions after Common IR Procedures: Readmission Rates and Association with Early Mortality.常见介入放射学操作后再入院的相关性:再入院率及与早期死亡率的关联
J Vasc Interv Radiol. 2017 May;28(5):629-636. doi: 10.1016/j.jvir.2017.01.008. Epub 2017 Mar 11.
8
Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.美国急性食管静脉曲张出血住院患者的早期经颈静脉肝内门体分流术
J Gastroenterol Hepatol. 2017 Apr;32(4):852-858. doi: 10.1111/jgh.13593.
9
Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.83884例经颈静脉肝内门体分流术患者住院死亡率的全国趋势及预测因素
World J Gastroenterol. 2016 Jul 7;22(25):5780-9. doi: 10.3748/wjg.v22.i25.5780.
10
Inpatient Cost Assessment of Transjugular Intrahepatic Portosystemic Shunt in the USA from 2001 to 2012.2001年至2012年美国经颈静脉肝内门体分流术的住院费用评估
Dig Dis Sci. 2016 Oct;61(10):2838-2846. doi: 10.1007/s10620-016-4233-z. Epub 2016 Jun 27.